US Biological Indicators Top Companies and Strategic Involvements

Top Companies in the U.S. Biological Indicators Market & Their Offerings

What are the Recent Developments in the U.S. Biological Indicators Market? 

• In June 2026, Director of National Intelligence (DNI) Tulsi Gabbard released evidence revealing the U.S. government has historically funded over 120 biological laboratories across 30+ countries. She claims these facilities handle dangerous pathogens and operate with limited oversight, aiming to support the executive order to halt high-risk "gain-of-function" research globally.
• In June 2025, Solventum launched the Attest Super Rapid Vaporized Hydrogen Peroxide (VHâ‚‚Oâ‚‚) Clear Challenge Pack, a ready-to-use sterilization monitoring solution that combines biological and chemical indicators in a single package. The product is designed to simplify sterilization validation, improve monitoring efficiency, and provide clear visual verification of sterilization performance.

Market Ecosystem Analysis

Supply Chain Analysis

R&D

• Research and development in the U.S. biological indicators industry is focused on improving sterilization validation through highly resistant microbial strains and advanced monitoring technologies. Current innovations emphasize rapid-readout biological indicators, digital data integration, and enhanced compliance with evolving regulatory standards to ensure reliable sterility assurance across healthcare and biopharmaceutical applications.
• Key Players: 3M Health Care, Mesa Laboratories, STERIS, Crosstex International, and Getinge.

Regulatory Approvals

• In the U.S., biological indicators are regulated as Class II medical devices and require FDA 510(k) clearance before commercialization. This regulatory framework ensures that biological indicators meet established safety, performance, and sterilization validation standards for use in healthcare, pharmaceutical, and medical device industries.
• Key Players: 3M Health Care, Mesa Laboratories, STERIS, Crosstex International, Getinge, Propper Manufacturing, and Terragene North America.

Patient Support and Services 

• In the U.S., biological indicator support services help healthcare facilities, dental clinics, and medical device manufacturers maintain effective sterilization practices and infection control standards. These services include product guidance, sterilization process validation, regulatory compliance support, load monitoring, and quality assurance to ensure reliable sterility outcomes and patient safety.
• Key Players: 3M Health Care, Mesa Laboratories, STERIS, Crosstex International, Getinge, Propper Manufacturing, and Terragene North America.

Competitive Landscape

Market Growth

The U.S. biological indicators market size was estimated at USD 185 million in 2025 and is predicted to increase from USD 426.06 million in 2026 to approximately USD 426.06 million by 2035, expanding at a CAGR of 8.7% from 2026 to 2035.